QUANTUMBIO INC

State College, PA · Biotech · Private

MovableType (MT), a computational algorithm for predicting protein-ligand binding affinities and poses using enhanced molecular dynamics and quantum mechanics methods

Grants
$9.1M
18 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
3 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A new approach to solvent determination in QM/MM-based X-ray crystallographic refinement$141,089
Federal grantDepartment of Health and Human Services · Phase I · A new approach to solvent determination in QM/MM-based X-ray crystallographic refinement$141,089
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Development and Deployment of the Movable Type Method for Drug Discovery and Desi$1,131,845
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Development and Deployment of the Movable Type Method for Drug Discovery and Desi$570,555
Federal grantDepartment of Health and Human Services · Phase II · Development and Deployment of the Movable Type Method for Drug Discovery and Desi$561,290
Federal grantDepartment of Health and Human Services · Phase II · Development of the Movable Type free energy method for ligand placement in X-ray crystallography$165,917
Federal grantDepartment of Health and Human Services · Phase II · Development of the Movable Type free energy method for ligand placement in X-ray crystallography$547,670
Federal grantDepartment of Health and Human Services · Phase II · Development of the Movable Type free energy method for ligand placement in X-ray crystallography$1,090,721
Federal grantDepartment of Health and Human Services · Phase II · Development of the Movable Type free energy method for ligand placement in X-ray crystallography$543,051
Federal grantDepartment of Health and Human Services · Phase II · Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination$153,126
Federal grantDepartment of Health and Human Services · Phase II · Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination$513,208
Federal grantDepartment of Health and Human Services · Phase II · Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination$1,026,416
Federal grantDepartment of Health and Human Services · Phase II · Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination$513,208
Federal grantDepartment of Health and Human Services · Phase II · Research and cloud deployment of enhanced sampling methods in MovableType$207,659
Federal grantDepartment of Health and Human Services · Phase I · Research and cloud deployment of enhanced sampling methods in MovableType$207,659
Federal grantDepartment of Health and Human Services · Phase II · Research and cloud deployment of enhanced sampling methods in MovableType$654,406
Federal grantDepartment of Health and Human Services · Phase II · Research and cloud deployment of enhanced sampling methods in MovableType$654,406
Federal grantDepartment of Health and Human Services · Phase II · Addressing Structural Disorder and Conformational Heterogeneity in Modern Therapeutic Modalities: A Unified X-ray/Cryo-EM QM/MM Ensemble Refinement Toolkit with Enhanced Density-Driven MD$254,182
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2932INDUSTRIAL SONOMECHANICS, LLC——
2933ADEPTHERA, LLC——
2934SELECTA BIOSCIENCES, INC.——
2935QUANTUMBIO INC——
2936CBS THERAPEUTICS, INC.——
2937Dayra Therapeutics——
2938Theramix LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.